Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Abroad (travel likely)RecruitingPHASE2
Conditions
Atopic Dermatitis · Atopic Dermatitis Eczema · Eczema · Eczema, Atopic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Corvus Clinical Trials, South San Francisco, California, United States
Contact: Study coordinator (Corvus Clinical Operations) · CPI-818-006_Inquires@Corvuspharma.com · 650-889-4390
Study leads
Isin Sinem Bagci, MD
Study Director
Corvus Pharmaceuticals, Inc.